CoQ10 Combination Therapy to Reduce Chemotherapy Side Effects

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chemotherapeutic agents for treating cancer cause severe side effects and there is a need for improved methods to treat oncological disorders with reduced side effects.

Innovation Solution

Administering Coenzyme Q10 (CoQ10) in combination with chemotherapeutic agents to enhance the efficacy of cancer treatment while mitigating side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemotherapeutic agents are administered to treat cancer, then tumor reduction and survival time are improved, but severe side effects occur

Engineering Contradiction:
Improvecancer treatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

CoQ10 acts as a mediator substance that modifies the interaction between chemotherapeutic agents and biological systems. It protects healthy cells from chemotherapeutic damage while allowing the drugs to maintain their anti-cancer efficacy, thereby reducing side effects without compromising treatment effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the physiological parameters of healthy cells through CoQ10 supplementation, enhancing their resistance to chemotherapeutic agents. This allows the system to tolerate higher drug concentrations or prolonged treatment durations, improving overall treatment effectiveness while managing side effects

Inventive Principle:
Principle #35Parameter changes

2Productivity

If higher doses of chemotherapeutic agents are used to improve tumor reduction, then cancer treatment effectiveness increases, but side effects become more severe

Engineering Contradiction:
Improvetumor reduction rateVSAvoidside effects
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

CoQ10 serves as a protective intermediary that enables the administration of higher chemotherapeutic doses by shielding healthy tissues from excessive drug exposure. This allows the system to achieve higher tumor reduction rates while maintaining acceptable side effect levels through the buffer provided by CoQ10

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If multiple chemotherapeutic agents are combined to enhance treatment efficacy, then cancer treatment effectiveness improves, but toxicity and side effects increase

Engineering Contradiction:
Improvecancer treatment efficacyVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

CoQ10 acts as a universal protective intermediary in combination chemotherapy regimens, mitigating the cumulative toxic effects of multiple agents. It protects cellular systems from the combined stress of multiple drugs while allowing each agent to contribute to overall treatment efficacy

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

CoQ10 provides beforehand cushioning by pre-establishing protective mechanisms in healthy cells before combination chemotherapy begins. This prior protection allows patients to tolerate multiple chemotherapeutic agents with reduced cumulative toxicity

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

CoQ10 enhances the effectiveness of chemotherapeutic agents, reducing side effects and improving survival time and tumor reduction in cancer treatment.

Implementation Method 1

CoQ10 is a popular nutritional supplement and can be found in capsule form in nutritional stores, health food stores, pharmacies, and the like, as a vitamin-like supplement to help protect the immune system through the antioxidant properties of ubiquinol, the reduced form of CoQ10

Methodology Applied
Scientific EffectAntioxidant properties: Oxidation

Data Source

PatentEP2983654B1Treatment of cancer using coenzyme q10 combination therapies
Publication Date: 2025.11.12 BPGBIO INC
  • EP2983654B1 patent drawingFigure 1
  • EP2983654B1 patent drawingFigure 2
  • EP2983654B1 patent drawingFigure 3

AI summary

Presented herein are methods for the treatment of oncological disorders by the co¬ administration of CoQ10 formulations and chemo therapeutic agents and/or surgery. The CoQ10 formulations may be at least one of intravenous, topical, or by inhalation. The chemo therapeutic agents may be at least one of antimetabolites or anthracyc lines. Co-administration of the CoQ10 formulations may be prior to, concurrent or substantially concurrent with, intermittent with or subsequent to the administration of the chemotherapy.